Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Recruiting · NCT06582017 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma | Adnexal Diseases, Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, breast cancer, breast disorder, breast neoplasm, carcinoma, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, hepatocellular carcinoma, kidney cancer, kidney disorder, liver disorder, lung cancer, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, transitional cell carcinoma, urinary system disorder, urothelial carcinoma | Recruiting | Phase 1 | 2026-08-27 | NCT06582017 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nammi Therapeutics Inc | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sanai Medical Center | Los Angeles | United States | 1 |
| Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer | Los Angeles | United States | 1 |
| Emory University - Winship Cancer Institute | Atlanta | United States | 11 |
| Froedtert Hospital & the Medical College of Wisconsin | Milwaukee | United States | 31 |
| Hoag Memorial Hospital Presbyterian | Newport | United States | 2 |
| New York Cancer & Blood Specialists | New York | United States | 1 |
| Sarah Cannon Research Institute - Denver DDU | Denver | United States | 1 |
| START San Antonio | San Antonio | United States | 30 |
| University of Rochester - Wilmot Cancer Institute | Rochester | United States | 3 |
| University of Southern California | Los Angeles | United States | 110 |